缺铁性贫血临床治疗的药物经济学分析

Pharmacoeconomical analysis of clinic treatment for iron deficiency anemia

目的:从医疗供给者的角度,对孕妇缺铁性贫血采用的二种不同治疗方法进行经济学分析,以期能对目前临床上对缺铁性贫血的治疗提供借鉴。方法:运用前瞻性、开放式随机双盲对照的研究手段,观察不同治疗方案的疗效和安全性,结合药物经济学研究方法中的最低限度分析法,对各种不同药物的治疗效果进行经济学评价。结果:各治疗方案的治愈率均为100%,两组结果无显著性差异(P>0.05),但经济学分析却显示,速力菲治疗组的成本低于天一血泰组。结论:在疗效相同的情况下速力菲组治疗方案优于天一血泰组。

Objective：To observe two different drug therapies for iron deficiency anemia in pregnant women from the point of medical prescriber.Methods：By prespective,open randomized,double blind controlled study,the therapeutic effects and security of every group were observed and evaluated economically on drug therapy and effects by the lowest line analysis in pharmacoeconomy.Results：The patients cure rate of two groups was 100%,there was no significant difference between two group,but the pharmacoeconomical analysis reveal that the cost of sulifei group was lower than that of the tianyixuetai group. Conclusion.The sulifei group is better than that of the tianyixuetai group under the circumstance of their equal therapeutical effects.